Yueyin Venture Capital

Yueyin Venture Capital is an investment institution that focuses on the healthcare industry. Its goal is to focus on patients, based on medical services, based on the three dimensions of disease type, new technology and industrial chain in medical services, medical devices, biomedicine and in vitro diagnostics, smart medical, and other fields. The firm was formed by people in the medical field and the investment field is committed to promoting the development of the domestic medical and health industry. Yueyin Venture Capital is dedicated to finding China's growth, innovation, entrepreneurship, and the medical health industry.

You Linlin

Executive Director

12 past transactions

Kossel Medical

Venture Round in 2022
Kossel Medical specializes in the research and development of vascular interventional medical devices. The company manufactures a range of products, including coronary stent systems, PTA balloon catheters, and electrophysiology devices. By focusing on these areas, Kossel Medical aims to enhance clinical treatment options for patients, providing innovative solutions in the field of interventional cardiology and vascular care.

GX Pharma

Venture Round in 2020
Operator of a CRO (Contract Research Organization) company engaged in medical and clinical research and development. The company focuses on providing overall solutions for clinical research services and registration applications for drugs, biological products, and medical devices, enabling the customers to shorten the product listing cycle and promote the product marketization process.

Hanyu Medical

Series B in 2018
Shanghai Hanyu Medical Technology Co., Ltd. specializes in the research and development of medical devices aimed at treating heart valve diseases. Established in 2016 and headquartered in Shanghai, with an additional office in Beijing, the company is recognized as one of the pioneering domestic firms in the development, production, and sale of transcatheter mitral valve repair devices. Hanyu Medical's flagship product, ValveClamp, is designed for minimally invasive interventions to address mitral valve regurgitation, enabling surgeons to close heart valves efficiently during procedures.

Yidianling

Series A in 2018
壹点灵 is a psychological counselor platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

Yidianling

Series A in 2018
壹点灵 is a psychological counselor platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

Rivamed

Series A in 2018
Provider of intelligent storage and logistics solutions intended to serve the medical field. The company's system is based on HIoT (Hospital Internet of Things) technology that integrates medical resources to increase the efficiency of medical staffs and decrease operational error rates.

Campo Imaging

Series A in 2017
Shenyang Campo Medical Imaging Technology Co., Ltd. is a Chinese provider of medical imaging services, established in 2010 and based in Benxi, China. As a subsidiary of Liaoning Kampo Medical System Co., Ltd., the company specializes in the development and production of medical imaging equipment and operates imaging centers. Campo Imaging offers a range of diagnostic services, including CT scans, magnetic resonance imaging, digital radiography, ultrasound, dynamic ECG, tele-consultation, and consultations for complex cases. The company's mission is to enhance the medical imaging experience, enabling patients to access essential diagnostic services efficiently and effectively.

GenomePrecision

Series A in 2017
Beijing GenomePrecision Technology Co., Ltd. is a molecular diagnostic company based in Beijing, China, specializing in the development of precision medicine tests. Founded in 2015, the company integrates research and development, manufacturing, and distribution to create a range of diagnostic products. These include tests for leukemia and lymphoma, transplant typing, solid tumor detection, pharmacogenomics, pathogen detection, and cervical cancer. GenomePrecision operates multiple advanced molecular technology platforms, such as real-time fluorescence quantitative PCR, Sanger sequencing, high-throughput next-generation sequencing, and capillary electrophoresis. The company also offers a variety of molecular diagnostic kits, including those for targeted drug testing and mycobacterium tuberculosis detection. By focusing on clinical diagnosis and treatment needs, GenomePrecision aims to provide innovative diagnostic solutions that enhance patient care.

Mingyizhudao

Series B in 2016
Mingyizhudao is a prominent Internet and surgery platform in China, recognized for its comprehensive mobile medical operation reservation service. Launched in March 2015, its flagship product, “Medical Doctor,” has established the company as an authoritative resource for surgical needs. The platform connects patients with over 40,000 top-tier medical experts from renowned hospitals and more than 100,000 grassroots doctors, facilitating optimal matches between patients and healthcare providers. By leveraging internet technology, Mingyizhudao aims to enhance the efficiency and safety of surgical services, ensuring that patients receive tailored care that meets their specific medical requirements. Additionally, the platform collaborates with over 1,000 partner hospitals across the country, reinforcing its commitment to improving access to quality surgical care.

InVision

Angel Round in 2016
Shanghai Invision Health Technology Company Limited is a digital technology agency focused on the medical industry. Established in 2013 and based in Shanghai, China, the company integrates advanced digital technologies with industry-specific knowledge to enhance communication and information dissemination in healthcare. Invision specializes in developing medical mobile applications, producing 3D medical visuals, and creating digital display solutions. Its innovative use of virtual reality technology aims to streamline the communication of medical information, thereby improving engagement and understanding within the medical community.

CN-Healthcare

Series B in 2016
Provider of an online healthcare information media platform designed to integrate healthcare industry information and news. The company's platform focuses on medical resource integration service and offers products including health industry website, mobile newspaper and mobile medical applications, enabling customers to have access to updated healthcare information and improve public understanding about health industry in an efficient manner.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.